205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
6.10%
Net income growth under 50% of ADI's 14.87%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-1.69%
Negative yoy D&A while ADI is 1.20%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-5800.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
7.69%
SBC growth while ADI is negative at -20.96%. John Neff would see competitor possibly controlling share issuance more tightly.
46.99%
Less working capital growth vs. ADI's 197.61%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
74.03%
AR growth of 74.03% while ADI is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
31.67%
Inventory growth of 31.67% while ADI is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
68.52%
AP growth of 68.52% while ADI is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-12.90%
Negative yoy usage while ADI is 197.61%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
471.43%
Some yoy increase while ADI is negative at -943.72%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
34.65%
Operating cash flow growth below 50% of ADI's 103.99%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-1.63%
Both yoy lines negative, with ADI at -107.19%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-174.33%
Both yoy lines negative, with ADI at -37.17%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
39.84%
Proceeds from sales/maturities above 1.5x ADI's 12.56%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-11600.00%
Both yoy lines negative, with ADI at -19.82%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-210.13%
Both yoy lines negative, with ADI at -680.41%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-79.27%
Negative yoy issuance while ADI is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
2.39%
Buyback growth below 50% of ADI's 59.29%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.